Sanofi to invest 610 millions euros at two French vaccines sites

MARCY-L’ETOILE, France (Reuters) – French drugmaker Sanofi on Tuesday said it would invest 610 million euros ($679.4 million) at two of its French sites to turn them into a hub dedicated to research, development and production of vaccines.

Investments will help enhance the capacities of the group’s sites at Marcy-L’Etoile and Neuville-sur-Saone, central France.

The announcement came as Sanofi officials hosted a visit of French president Emmanuel Macron at Sanofi’s Marcy-L’Etoile facility on Tuesday.



Share this page Share on FacebookShare on TwitterShare on Linkedin

Listen to 'Radio FCCIB' Videos & Podcast

Radio FCCIB is the new program launched by the French Chamber of Commerce & Industry in Bahrain, asking 3 questions to its members